Key facts
- In September 2025, 90 measles cases were reported by 11 countries in the EU/EEA. 17 countries reported zero cases.
- During the last 12-month period, eight deaths attributable to measles were reported to ECDC by Romania (five), France (two) and the Netherlands (one)
- Overall, case numbers decreased compared with the previous month; this is consistent with the seasonality of measles.
- Supplementary epidemic intelligence surveillance was performed on 13 and 14 November 2025. Sporadic cases were reported by several EU/EEA countries, an ongoing outbreak was reported in one outermost region in Canary Islands. Updates are provided for countries outside EU/EEA.
Overview
Since March 2025, an overall decrease in reported cases has been observed. A further decline in case numbers was expected over the summer months, in line with the known seasonality of measles.
In September 2025, 28 countries reported measles data, with 90 cases reported by 11 countries. There were 17 countries that reported zero cases.
Overall, case numbers decreased compared with the previous month, however this may be subject to change in the event of a future retrospective update. The highest case counts were reported by Italy (27), Netherlands (18), Germany (14), Belgium (nine) and Romania (seven).
Between1 October 2024 to 30 September 2025, 30 EU/EEA Member States reported a total of 10 195 measles cases, 7 265 (71.3%) of which were laboratory confirmed. Of the 10 195 cases with known age, 4 127 (40.5%) were in children under five years; 3 312 (32.5%) cases were aged 15 years or above. The highest notification rates were observed among infants under one year of age (336.4 cases per million) and children aged 1-4 years (174.6 cases per million).
Of 10 197 cases (100.0% of all cases) with a known age and vaccination status, 8 270 (81.1%) were unvaccinated, 1 003 (9.8%) were vaccinated with one dose of a measles-containing vaccine, 709 (7.0%) were vaccinated with two or more doses, and 197 (1.9%) were vaccinated with an unknown number of doses.
During the 12-month period, eight deaths (case fatality rate (CFR): 0.074%) attributable to measles were reported to ECDC by Romania (five), France (two) and Netherlands (one). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.
Complementary epidemic intelligence surveillance has been conducted, with data collection between 13 and 14 November 2025. An ongoing/active outbreak has been detected in the Canary Islands; sporadic cases have been reported by several EU/EEA countries. Outside the EU/EEA, updates have been provided for England, Ukraine, Canada, US and Mexico, as well for WHO AFRO and WHO PAHO regions.
Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to EpiPulse Cases. Data presented in the two monthly reports may differ.
Epidemiological summary for EU/EEA countries with relevant epidemic intelligence updates:
Austria reported 152 measles cases in 2025 as of 12 November 2025, an increase by three cases since October 2025.
Bulgaria reported one new case in week 46, this is a second case in 2025 (first case was reported in week 11).
Denmark reported eight measles cases in 2025 as of 13 November 2025, an increase of one case since 5 August 2025.
France has reported 858 cases from 1 January to 31 October 2025, including two deaths, an increase of 56 cases since 14 August 2025 (eight cases reported in October). No active clusters nor outbreaks have been reported in the past month of the reporting period.
Germany reported 267 confirmed and probable measles cases in 2025 and as of 13 November, an increase by 30 case since 7 October 2025. No outbreaks have been detected by ECDC EI group.
Hungary reported six cases of measles in 2025 and as of 2 November, an increase of one since 27 July 2025. The last case was reported in week 44 of 2025.
Italy reported 459 cases of measles form 1 January to 30 September 2025, an increase of 27 cases since August 2025.
The Netherlands reported 526 cases of measles as of 5 November, 20 more cases since 10 September 2025. The recent cases are sporadic and family related. There is no indication of a national outbreak. In 2025, 62 cases were reported to have contracted measles abroad, with most of these infections being related to travel to Morocco (39). Other cases had travel histories to Greece, Romania, Vietnam, Türkiye, Belgium, Uganda, Iran, Bosnia and Herzegovina, China, Malaysia, France, Somalia, and Italy.
Romania reported 8 433 measles cases and eight deaths in 2025 and as of 31 October 2025, an increase of 64 cases since 30 September 2025. No new deaths were reported in the reporting period. A decreasing trend is observed in 2025, with fewer cases reported per month compared to the same period in 2024.
Spain reported 379 cases as of 9 November 2025, an increase of 35 cases since 30 September 2025. Of the reported cases, 108 were imported and 92 were related to imported cases. One outbreak was detected in the Canary Islands.
Epidemiological summary for EU/EEA outermost territories with relevant epidemic intelligence updates:
Canary Islands: On 10 November 2025, the Canary Islands Health Service Directorate provided an update on an ongoing outbreak of measles, with 21 cases reported in the islands of La Palma, Gran Canaria and Tenerife. This week, seven cases have been reported in La Palma (five adults) and Gran Canaria (two cases). The recent cases have mild disease and are recovering without complications. The outbreak started on 20 October 2025 with three cases, including two children (one over 12-months of age, one small child ineligible for vaccination due to age, and a healthcare worker). Epidemiological investigation revealed the index case had contact with a case in Tenerife, that was detected several days earlier. The authorities are conducting follow-up of the people who may have come into contact with confirmed cases.
Epidemiological summary for select countries outside of the EU/EEA with relevant epidemic intelligence updates:
England reported 811 laboratory confirmed cases from January to 23 October 2025, 69 more cases since 18 August 2025. After several outbreaks, which started in April 2025, the number of cases shows a downward trend since mid-July 2025. The majority of cases involve children under 10 years of age (69%).
Ukraine reported 1 446 measles cases from January to September 2025.
On 10 November 2025, the Public Health Agency of Canada published a statement that Canada no longer holds measles elimination status as per The Pan American Health Organization (PAHO) notification to the country, due to an ongoing multi-jurisdictional outbreak that has lasted for over 12 months.
As of 10 November 2025, Canada reported 5 162 cases, including two deaths, both of which occurred in congenital cases of measles who were born pre-term. An ongoing multijurisdictional outbreak affects 10 jurisdictions. Most of the reported cases are linked to this outbreak (5 099 cases, of which 4 707 confirmed, 392 probable).
According to the report by Africa CDC published on 6 November 2025, a total of 129 680 measles cases (11 061 confirmed) and 1 110 deaths (CFR: 0.79%) have been reported from 20 countries: Cameroon, Chad, Democratic Republic of the Congo, Ethiopia, Guinea, Kenya, Malawi, Mali, Mauritania, Morocco, Mozambique, Namibia, Nigeria, Rwanda, Senegal, Somalia, South Africa, Sudan, Uganda, Zambia.
According to the WHO Pan American Health Organization (WHO PAHO) report published on 18 October 2025, 12 317 confirmed cases were reported by 10 countries, of which the majority of cases reported in Canada (5 109), Mexico (5 019), and the United States (1 614).
As of 13 November 2025, the US has reported 1 723 confirmed measles cases in 2025, including three deaths in 43 jurisdictions. Ninety-two percent of the cases were in people who were unvaccinated or had an unknown vaccination status. Eighty-seven percent of the cases were associated to 45 outbreaks.
As of report on 13 November 2025, Mexico has reported 5 257 confirmed cases, including 23 deaths in weeks 1–43 of 2025. Most of the cases are reported in the region Chihuahua (4 440 confirmed cases, including 21 deaths). One death was reported in Durango with 40 confirmed and 280 probable measles cases.
For more information on the provisional number of cases outside the EU/EEA region, please visit the WHO website.
The numbers provided to WHO for EU/EEA countries are from EpiPulse Cases data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.
ECDC assessment
Although most recent cases were acquired through local or community transmission, travel-related cases continue to be reported.
Continued vigilance is essential due to suboptimal vaccination coverage for measles-containing vaccines (MCV) in several EU/EEA countries, the possible introduction from areas with ongoing transmission, and increased travel and population movement during the holiday period.
Actions
ECDC is monitoring the measles situation through its epidemic intelligence activities. Data collected via epidemic intelligence supplement the monthly outputs that present measles surveillance data from EpiPulse Cases, which are routinely submitted by 30 EU/EEA countries.
ECDC urges EU/EEA public health authorities to focus on the following areas:
- Close immunity gaps, achieve and maintain high vaccination coverage for MCV (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time, as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
- Strive towards high-quality surveillance and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
- Increase the clinical awareness of health professionals, including reminding them of the importance of checking individuals' vaccination status ahead of travel.
- Healthcare professionals should be fully vaccinated.
- Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of suboptimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
- Address barriers and engage with populations under served by healthcare services. Systemic barriers that impact vaccine uptake in populations which are isolated and under-served by healthcare services need to be monitored and addressed with targeted strategies in order to reduce inequalities in vaccine uptake.
- In light of the upcoming summer holiday season, travellers should check their vaccination status and consult their general practitioner to ensure they are up to date with recommended immunisations prior to departure.
ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response', published in February 2024 and the conclusions remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.